Originally published In Press as doi:10.1074/jbc.M200950200 on March 14, 2002
J. Biol. Chem., Vol. 277, Issue 22, 19967-19975, May 31, 2002
In Vitro Evidence That the Untranslated
Leader of the HIV-1 Genome Is an RNA Checkpoint That Regulates Multiple
Functions through Conformational Changes*
Ben
Berkhout
§,
Marcel
Ooms
,
Nancy
Beerens
,
Hendrik
Huthoff
,
Edwin
Southern¶, and
Koen
Verhoef¶
From the
Department of Human Retrovirology, Academic
Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ
Amsterdam, The Netherlands and the ¶ Department of
Biochemistry, Oxford University,
Oxford OX1 3QU, United Kingdom
Received for publication, January 29, 2002, and in revised form, March 12, 2002
 |
ABSTRACT |
The HIV-1 RNA genome forms dimers through base
pairing of a palindromic 6-mer sequence that is exposed in the
loop of the dimer initiation signal (DIS) hairpin structure (loop-loop
kissing). The HIV-1 leader RNA can adopt a secondary structure
conformation that is not able to dimerize because the DIS hairpin is
not folded. Instead, this DIS motif is base-paired in a long distance
interaction (LDI) that extends the stem of the primer-binding site
domain. In this study, we show that targeting of the LDI by either
antisense oligonucleotides or specific mutations can induce the
conformational switch to a branched multiple hairpin (BMH) structure,
and this LDI-to-BMH switch coincides with increased RNA dimerization.
Another interesting finding is that the extended LDI stem can resist a certain level of destabilization, indicating that a buffer is created
to prevent a premature conformational switch and early dimerization.
Because the tRNALys3 primer for reverse transcription
anneals to multiple sequence elements of the HIV-1 leader RNA,
including sequences in the LDI stem, we tested whether tRNA-annealing
can destabilize the LDI stem such that RNA dimerization is triggered.
Using a combination of stem-destabilizing approaches, we indeed
measured a small but significant effect of tRNA-annealing on the
ability of the RNA template to form dimers. This observation
suggests that HIV-1 RNA can act as a checkpoint to control and
coordinate different leader functions through conformational switches.
This in vitro result should be verified in subsequent
in vivo studies with HIV-infected cells.
 |
INTRODUCTION |
The untranslated leader region of the
HIV-11 RNA genome contains
multiple regulatory motifs that play important roles in the viral
replication cycle (1, 2). Distinct functions have been assigned to
individual sequence and/or structure motifs (see Fig. 1A).
The 5'-terminal TAR hairpin forms the binding site for the viral
Tat protein and the cellular cyclin T protein (3, 4). The formation of
this RNA-protein complex on the nascent transcript is essential for
high level transcription from the LTR promoter (5). The poly(A) hairpin
also functions as part of the nascent transcript. The structure
inhibits polyadenylation through the masking of the AAUAAA
polyadenylation signal (6, 7). Both the TAR and poly(A) sequences are
part of the terminal repeat (R), and a second copy is present at the
extreme 3'-end of the viral RNA genome. At this position, inhibition of
polyadenylation by the suppressive RNA structure is overcome by an
upstream enhancer element that facilitates the binding of the
CPSF polyadenylation factor. Thus, the upstream TAR and poly(A)
hairpins play pivotal roles during the early phase of viral gene
expression. In addition, these structure motifs in the R region also
participate in later phases of the viral replication cycle (2),
e.g. in the strand transfer reaction during the process of
reverse transcription (8).
Several RNA motifs are located further downstream in the untranslated
leader RNA. An extended structure domain encompasses the primer-binding
site (PBS) that binds the tRNALys3 primer for reverse
transcription. Whereas the PBS motif is largely exposed within this
structured RNA domain, there is some recent evidence for an additional
upstream tRNA interaction site that is actively masked by base pairing
in the extended PBS stem. This primer activation signal (PAS) is not
involved in tRNA-annealing, but is essential for efficient initiation
and elongation of reverse transcription (9, 10). Further downstream we
find structure motifs that have been implicated in dimerization and
packaging of the HIV-1 RNA into virion particles. The dimer initiation
signal (DIS) folds a hairpin structure that exposes a 6-mer palindrome sequence within the loop, and two DIS motifs can form a
"kissing-loop" complex by base pairing (11-16). This RNA dimer is
further stabilized by melting of the stem regions and subsequent
formation of a more extended intermolecular duplex (17). The PSI region
binds the viral nucleocapsid (NC) protein and has been implicated in
the selective packaging of the HIV-1 RNA into virion particles (18, 19). Thus, a multitude of critical RNA signals are clustered in the 336 nucleotides of the untranslated leader. The functional analysis of
these motifs in replication studies with mutant viruses is seriously
complicated by the overlap of some of these RNA replication signals.
This problem is less severe in defined biochemical assays that focus on
a particular RNA function, e.g. RNA dimerization with
in vitro synthesized transcripts.
A static secondary structure model of the HIV-1 leader RNA has been
proposed (1). However, we recently presented evidence that the HIV-1
leader does not constitutively adopt the conformation that is
characterized by the multiple hairpins as shown in Fig. 1A.
In fact, the HIV-1 leader RNA folds into a more stable alternative conformation that appears to regulate the process of RNA dimer formation (20). Specifically, we demonstrated that the poly(A) and DIS
sequences can base pair, thereby masking the DIS palindrome and
actively inhibiting RNA dimerization (21). This long distance interaction (LDI) extends the stem region that forms the basis of the
structured PBS domain (Fig. 1, B and C), and this
RNA conformation is characterized by a typical fast migration on
non-denaturing gels. The LDI conformation is thermodynamically more
stable than the alternative conformation that we termed the branched
multiple hairpin (BMH) structure. However, the viral NC protein can
induce the latter structure, concomitant with increased RNA
dimerization. It thus appears that the extended PBS stem region is
involved in the regulation of both the reverse transcription and
dimerization reactions through masking of the PAS and DIS elements.
This dynamic property of the leader RNA structure may serve to
coordinate the early and late replication functions, and we proposed
the idea of an RNA checkpoint that regulates different leader RNA
functions in a temporal manner.
We performed a detailed in vitro analysis to further study
the extended stem of the PBS domain and its influence on the structure and function of the HIV-1 leader RNA. The results indicate that the
extended PBS stem can absorb minor mutations, but that progressive destabilization of the base-pairing potential does eventually trigger
the LDI-to-BMH structural switch and subsequent RNA dimerization. In
this sensitive assay system, we were also able to measure a modest
effect of tRNA-PBS-annealing on the overall leader RNA conformation and
its dimerization properties. These results provide the first evidence
that the reverse transcription and dimerization reactions may be
coupled through conformational changes within the leader RNA.
 |
EXPERIMENTAL PROCEDURES |
HIV-1 Templates for PCR and Transcription--
Wild-type and
mutant plasmids were used for PCR amplification and subsequent in
vitro transcription. Plasmid Blue-5'-LTR (22) contains an
XbaI-ClaI fragment of the HIV-1 subtype B
molecular clone LAI (23). This HIV-1 fragment contains the complete
5'-LTR, PBS, leader, and the 5'-end of the gag gene
(positions
454 to
376 relative to the transcriptional start site,
+1), which was cloned into pBluescript KS+ (Stratagene). The
construction of all mutants that target the U5-leader stem has been
described previously (10). The 4-nucleotide deletion within the DIS
hairpin loop of mutant GC1 was introduced as described (24).
The wild-type and mutant plasmids were used as templates for PCR
amplification. The T7 promoter sequence was introduced into the PCR
product with sense primers containing the T7 promoter sequence. The T7
promoter sequence was inserted immediately upstream of positions +1 or
+92 with the sense primers T7-1 and T7-92. The oligonucleotide 290/270
was used as the antisense PCR primer. DNA products were separated on an
agarose gel and extracted with the QIAEX II DNA isolation system
according to the manufacturer's instructions.
RNA transcripts were produced with the megashortscript T7 transcription
kit (Ambion) in the presence of 1 µl of [
-32P]UTP
(0.33 MBq/µl, Amersham Biosciences) according to the manufacturer's instructions. The RNA was purified on a 4% denaturing polyacrylamide gel. Bands were visualized by autoradiography and excised from the gel,
and RNA was eluted overnight in water at room temperature. The RNA was
precipitated and dissolved in RNase-free water. RNA was renatured by
incubation for 2 min at 85 °C, 10 min at 65 °C, and subsequent
slow cooling to room temperature. RNA was quantified by scintillation
counting, and the samples were stored at
20 °C.
In Vitro RNA Dimerization--
Dimerization was performed with
~20 ng of 32P-labeled RNA in 24 µl of dimerization
buffer (5 mM MgCl2, 83 mM Tris-HCl,
pH 7.5, 125 mM KCl). Depending on the type of experiment,
we added 200 ng of oligonucleotide or tRNA (1, 4, or 8 µg of calf
liver tRNA, Roche Molecular Biochemicals). The mixture was heated for 2 min at 85 °C and was subsequently incubated for 10 min at 65 °C
and slow cooled to room temperature in ~1 h for renaturing and
dimerization. We added 12 µl of loading buffer (30% glycerol with
bromphenol blue), and the samples were analyzed both on a TBE gel (4%
non-denaturing acrylamide gel in 0.25× TBE) and on a TBM gel (same as
the TBE gel but with 0.1 mM MgCl2).
Electrophoresis was performed at 150 V at room temperature and was
followed by drying and autoradiography. Quantitation of the percentage
dimerization was performed on a PhosphorImager (Molecular Dynamics).
Array Synthesis--
Arrays comprising every possible 5- to
25-mer antisense oligonucleotide scanning HIV sequences +1 to +331 were
synthesized using solid phase DNA chemistry. Oligonucleotides were
synthesized in situ by delivery of phosphoramidite
precursors to the surface of a derivatized microscope glass slide using
inkjet technology. Standard DNA chemistry couples the precursors to the
array surface or the growing DNA chain and repeated rounds of synthesis
create oligonucleotides of specific sequence and length that are
spatially addressable (25, 26).
Array Probes; PCR, in Vitro Transcription, and Fluorescent
Labeling--
In vitro transcripts were prepared from a
double-stranded DNA template containing a T7 RNA polymerase promoter
generated by standard PCR from plasmid pBlue-5'-LTR (22) with primers
T7-2 (6) and an antisense HIV primer hybridizing with the 5'-end to HIV
nucleotide +290. PCR products were gel-purified and transcription reactions were performed with the Megashortscript T7 transcription kit,
and transcripts were purified over a G50 spin column. Cy5 labeling was
performed post-transcriptionally using the ULYSIS Cy5 labeling kit
(Kreatech). RNA concentration and labeling density (~1 Cy5 group per
34 nucleotides) were determined by spectrophotometry.
Array Hybridization, Data Acquisition, and
Analysis--
Hybridizations were performed in a 280-µl reaction
containing TEN buffer (100 mM NaCl, 1 mM EDTA,
10 mM Tris, pH 8.0), supplemented with 1% Triton X-100.
Transcripts (12 fmol of RNA or 100 fmol of Cy5) were heated to 85 °C
and slowly cooled to room temperature in the presence or absence of the
151/123 oligonucleotide (50 pmol) (21). Array hybridizations were
performed for 16 h at room temperature under constant rotation of
the hybridization chamber. Hybridization chambers were emptied and
disassembled, and the array was quickly placed in a 50-ml Falcon tube
containing 1× TEN buffer with 0.1% Triton, washed for 30 s by
inverting the tube, placed in a second tube containing 0.1× TEN, and
washed for a further 30 s with mixing. The array was slowly pulled
from the final washing solution while being blown dry with a nitrogen gun at close range. The arrays were subsequently scanned in a Agilent
confocal array scanner at 10-micron resolution. The Agilent feature
extraction software package was used to automatically detect
oligonucleotide features in the hybridization image, and the resulting
data were corrected for local background for each individual feature.
Hybridization signals that did not pass the stringent quality tests or
that were at or below background signal levels were discarded. The
experimental data were exported to a tab-delimited text file and were
imported in spreadsheet software for detailed analysis.
 |
RESULTS |
Targeting of the Extended PBS Stem by Antisense
Oligonucleotides--
To study the effect of the extended PBS stem
region on the LDI-BMH equilibrium and DIS-mediated RNA dimerization, we
targeted the HIV-1 leader RNA with a set of antisense DNA
oligonucleotides. The transcript-oligonucleotide complexes were
analyzed on non-denaturing TBE and TBM gels to distinguish the
different leader RNA conformations; the two monomer forms (the fast
migrating LDI and the BMH forms) and RNA dimers. The HIV-1 transcript
1-290 that is shown in detail in Fig.
1C stably adopts the fast
migrating LDI conformation on the TBE and TBM gels (lane 1 in Fig. 2, A and B,
respectively). Oligonucleotides targeting the TAR region (lanes
2 and 3) do not affect the LDI conformation and do not
induce RNA dimer formation. Oligonucleotides that target the poly(A)
domain do trigger the LDI-to-BMH rearrangement. This is clearly
demonstrated on the TBE gel by the appearance of the slow migrating BMH
form (Fig. 2A, lanes 4-6). Consistent with
previous results (27), the LDI form refolds during electrophoresis on
the TBM gel (Fig. 2B, lanes 4-6). Most
importantly, the LDI-to-BMH switch coincides with increased formation
of RNA dimers (D), at least for the 104/77 and 122/99 oligonucleotides. The RNA dimers are apparent on the TBE gel (Fig. 2A, lanes 5 and 6), but dimers are
more prominent on the TBM gel (Fig. 2B, lanes 5 and 6). The TBM gel yields the highest dimerization level
because labile kissing-loop RNA dimers do survive electrophoresis in
the presence of magnesium.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
The alternative LDI and BMH foldings of the
HIV-1 leader RNA. A, the primary structure of the HIV-1
leader RNA with the different regulatory domains and the classical
hairpin conformation. This multihairpin structure may be adopted by the
nascent HIV-1 transcript. B, the mature HIV-1 RNA refolds
into the more stable LDI conformation in which the poly(A) and DIS
domains are base-paired. Formation of the BMH structure requires
disruption of the LDI stem through the annealing of antisense
oligonucleotides, the use of RNA mutants or the addition of NC protein.
The DIS hairpin is exposed in the BMH structure, thus facilitating
subsequent RNA dimerization. C, the detailed base-pairing
scheme of the LDI conformation. The PBS (marked in blue) is
the primary binding site for the tRNALys3 primer. In
addition, the upper stem segment of the extended LDI structure contains
the recently identified PAS element that makes a secondary contact with
the tRNALys3 primer.
|
|

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 2.
Antisense oligonucleotide probing of the
LDI-BMH equilibrium and HIV-1 RNA dimerization. The 1-290 HIV-1
leader transcript was incubated with the antisense probes that are
indicated on top of the gel with the respective leader RNA
target positions. The samples were analyzed on TBE and TBM gels
(panels A and B). The positions of the fast
migrating LDI form, the alternative BMH fold, and RNA dimers
(D) are marked with arrowheads.
|
|
We initially tested five oligonucleotide probes that cover most of the
PBS domain. All these oligonucleotides mediate the LDI-to-BMH switch
(Fig. 2A, lanes 7-11), but the 181/152 and
202/182 probes show a partial transition (lanes 8 and
9). This trend translates directly into the dimerization
capacity of HIV-1 RNA, which is strongly induced by oligonucleotides
151/123 and 223/200 that target the left and right side of the extended
PBS stem, respectively. A very minor stimulation of RNA dimer formation
is observed with probes 181/152 and 202/182, and oligonucleotide
245/216 induces an intermediate level of RNA dimers. The same samples
were also analyzed on the TBM gel that stabilizes the dimer
conformation (Fig. 2B). The ranking order of the dimer
induction properties of the antisense oligonucleotides in the PBS
domain is 151/123 > 223/200 > 245/216 > 181/152 > 202/182.
The probe 245/216 anneals very close to the DIS hairpin, apparently
without preventing its dimerization function. However, we observed a
severe dimerization defect when the probe is extended by three
nucleotides toward the DIS element (probe 248/216, results not shown).
We show two control reactions with other anti-DIS oligonucleotides
(269/246 and 290/270). As expected, these probes do effectively trigger
the LDI-to-BMH switch, but they block subsequent RNA dimerization by
shielding of the actual dimerization motif (Fig. 2, A and
B, lanes 12 and 13). These results
demonstrate that the DIS motif is solely responsible for in
vitro dimerization of HIV-1 RNA. This was confirmed in studies
with a mutant transcript with a truncated palindrome (GCGCGC to GC)
that did not form dimers under these conditions (results not shown).
We observed an almost perfect correlation between the ability of
certain antisense oligonucleotides to mediate the LDI-to-BMH switch and
their stimulatory effect on RNA dimerization. This result reinforces
the idea that RNA dimer formation is prevented by the LDI conformation
and that dimerization occurs spontaneously for BMH-folded transcripts.
However, it cannot be excluded that the oligonucleotides have a more
direct impact on the RNA dimerization reaction. To critically test this
possibility, we used the TAR-deleted HIV-1 transcript 92-290 that
exclusively folds into the BMH structure. Such transcripts indeed form
dimers at a reasonable efficiency (27). Most importantly, none of the
antisense oligonucleotides that stimulate dimerization of the wild-type
transcript have an effect on the dimerization properties of this
5'-truncated transcript (results not shown). These combined results
demonstrate that RNA dimerization is a direct consequence of the
LDI-to-BMH conformational switch of the HIV-1 leader RNA.
Targeting of the PAS Stem Affects the Leader RNA
Conformation--
The results described thus far indicate that
oligonucleotide-mediated targeting of the PBS domain can affect the
LDI-BMH equilibrium but not all subdomains react similarly. Targeting
of the PBS motif and the directly flanking sequences only marginally
affected the level of RNA dimerization. Disruption of the PBS stem by
DNA probes that bind either to the left side (151/123) or the right
side (223/200) seems the most effective trigger of the LDI-to-BMH
conformational switch, as measured by induction of RNA dimerization. To
corroborate this result, we analyzed additional antisense
oligonucleotides that target slightly shifted leader RNA domains. In
brief, these oligonucleotides exhibit profound differences in their
effect on the LDI-to-BMH equilibrium and concomitantly on the
dimerization properties of the transcript. For instance, probe 151/123
induces RNA dimer formation as is the case when a more upstream leader sequence is targeted (132/104). However, a downstream shift (161/133) results in an almost complete loss of the ability to induce the BMH
conformation and RNA dimerization (Fig.
3, A and B, lane
4). Probe 223/203 targets the right side of the LDI stem and
effectively triggers RNA dimerization. Compared with this probe, a
significant loss in dimerization was observed when a more upstream site
is targeted (202/182, see Fig. 2). Similarly, less dimers are induced when a more downstream site is targeted (245/216 and 245/225, Fig. 3).
These results indicate that maintenance of the upper part of the PBS
stem, that is the PAS-containing segment, is critical for maintenance
of the extended PBS stem and stable LDI folding of the HIV-1 leader
RNA.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 3.
Fine mapping of the antisense probe that most
effectively disrupts the LDI folding. The 1-290 HIV-1 leader
transcript was incubated with a set of antisense probes
(oligonucleotide termini are indicated on top of the gel).
Three probes target the left side of the LDI stem (lanes
2-4), three probes the right side (lanes 5-7), and a
control anti-DIS probe (lane 8) was included to show the
LDI-to-BMH switch. The samples were analyzed on TBE and TBM gels
(panels A and B). The positions of the fast
migrating LDI form, the alternative BMH fold, and RNA dimers
(D) are marked with arrowheads.
|
|
One obvious problem with the use of oligonucleotides as antisense
probes is that a length of about 20 nucleotides is required to ensure
annealing onto the RNA template. Thus, the PAS stem cannot be targeted
more specifically by this approach. We therefore synthesized mutant
HIV-1 transcripts with more defined, precise alterations. A set of 18 transcripts with mutations in the PBS domain was analyzed, but we will
focus on mutants that target the PAS-containing stem segment. The left
side was altered in mutant 2L, the right side in mutant 2R, and the 2LR
double mutant restores the base pairing possibility (28). As a control,
we also included the 3L mutant that alters the sequence directly upstream of the PAS element. All these mutations have a partial effect
on the LDI-BMH equilibrium, but they do not detectably induce RNA
dimerization (Fig. 4, A and
B). The most significant conformational shift is apparent
for the 2L and 2R mutants (Fig. 4A, lanes 2 and
3), and this effect is less apparent when base pairing is
restored in the 2LR double mutant (lane 4). Mutant 3L shows
a marginal LDI-to-BMH shift (lane 5). These results are consistent with the proposed modulatory role of the PAS stem, but it is
also apparent that the precise disruption of the base pairs of the PAS
stem segment is not sufficient to trigger a complete LDI-to-BMH switch
and subsequent RNA dimerization. To test whether more dramatic
mutations can force a complete conformational switch, we analyzed the
D1 deletion mutant that removes nearly the complete left side of the
PBS domain (positions 112-148), including the PAS element (28).
Indeed, this radical mutation caused a complete LDI-to-BMH switch (Fig.
4A, lane 6; note that this transcript is much
shorter than the wild-type control), which endows this transcript with
the property to dimerize (Fig. 4, A and B,
lane 6).

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 4.
HIV-1 RNA mutants and the effect on the
LDI-BMH equilibrium and RNA dimer formation. The PAS-containing
stem segment is mutated in mutant 2L
(125CUCUGGU131 to GAGACCA) and mutant 2R
(217ACCAGAG223 to UGGUCUC), and 2LR is the
double mutant. The segment upstream of the PAS is mutated in 3L
(118UGUGU122 to ACGCA). The deletion mutant D1
lacks nucleotides 112-148. The wild-type and mutant 1-290 transcripts
were incubated as described, and the samples were analyzed on TBE and
TBM gels (panels A and B). The positions of the
fast migrating LDI form, the alternative BMH fold, and RNA dimers
(D) are marked with arrowheads.
|
|
The inverse correlation between the stability of the LDI stem and the
dimerization properties of the transcript was also probed with mutants
that further stabilize the extended LDI stem. Virus mutants with these
RNA genomes were previously reported to exhibit a severe replication
defect, and phenotypic revertants were isolated that open up the stem
region by additional mutations (29). We measured a total RNA
dimerization defect for these mutants (results not shown). This RNA
dimerization defect is likely to have contributed to the virus
replication defect, but these mutant RNA templates also exhibit reverse
transcription defects (29).
tRNA-annealing and Its Effect on the Leader RNA Structure and
Function--
Disruption of the PAS stem segment influences the
overall folding of the HIV-1 leader RNA; the LDI-BMH equilibrium is
shifted to the BMH conformation, and dimerization is induced to some
extent. Interestingly, it has recently been proposed that the opening of the PAS stem occurs during initiation of reverse transcription. The
tRNALys3 primer first anneals onto the PBS, but an
additional interaction with the PAS element is required for efficient
initiation of reverse transcription (9, 10, 30). Thus, a scenario can
be proposed in which reverse transcription events (the initial tRNA-PBS
complex formation and subsequent tRNA-PAS interaction) affect the
leader RNA conformation (LDI-to-BMH switch) and possibly some of the leader RNA-associated functions (e.g. dimerization). We set
out to study the effect of tRNALys3-annealing on the
structure and dimerization function of the HIV-1 leader RNA. To mimic
the natural reverse transcription process, one would ideally assemble
the vRNA-tRNA complexes with viral proteins such as the reverse
transcriptase (RT) enzyme or the NC protein/Gag-p55 precursor.
We tried this approach, but these protein-RNA samples turned out to be
too complex to allow a straightforward identification of the different
RNA structures (LDI, BMH, and D) by their electrophoretic mobility.
The tRNALys3 primer or the anti-PBS DNA probe 202/182 were
heat-annealed onto the 1-290 transcript, and the complexes were
analyzed on TBE and TBM gels (Fig. 5,
A and B, lanes 1-7). We included oligonucleotide 151/123 that triggers the LDI-to-BMH switch and RNA
dimerization (lane 7) and anti-DIS oligonucleotide 269/246 that also mediates the switch but effectively blocks dimerization (lane 6). We tested three tRNA concentrations (1, 4, and 8 µg) none of which triggered RNA dimerization of the 1/290 transcript by tRNA-annealing (lanes 2-4). A similar result was
obtained with the anti-PBS probe, although a low level of RNA dimer is
formed (lane 5). The HIV-1 transcript clearly runs slower
during electrophoresis upon incubation with 4 and 8 µg of tRNA
(lanes 2 and 3), which may suggest LDI-to-BMH
refolding. Even though this complex migrates at the position that is
expected for a wild-type BMH transcript, the reduced gel migration
could also be the direct result of tRNA-annealing and shifting of the
transcript band on the gel (the 76-nucleotide tRNA is significantly
larger than the DNA probes). To discriminate between these two
possibilities, we used the 5'-truncated transcript 92-290 that
exclusively folds the BMH conformation, such that the magnitude of the
tRNA bandshift can be compared. The transcript-tRNA complexes were
analyzed on TBE and TBM gels (Fig. 5, A and B, lanes 8-14). Whereas the full-length 1-290 transcript
adopts the ground-state LDI conformation, the 92-290 transcript favors
the BMH conformation, and this transcript is dimerization-prone
(lane 8). We observed the same bandshift upon tRNA-annealing
to either the mutant BMH transcript (lanes 9 and
10) or the wild-type LDI transcript (lanes 2 and
3). This suggests that tRNA-annealing on the wild-type
transcript only triggers a tRNA bandshift, and no further shift is
observed that is caused by the LDI-to-BMH conformational switch.

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 5.
The effect of tRNALys3 primer
annealing on the LDI-BMH equilibrium and HIV-1 RNA dimerization.
The 1-290 (lanes 1-7) and 92-290 (lanes 8-14)
transcripts were incubated with the reagents indicated on
top of the gel. We tested three tRNA concentrations (1, 4, and 8 µg). The samples were analyzed on TBE and TBM gels
(panels A and B). For transcript 1-290, we
marked the position of the fast migrating LDI form, the
LDItRNA complex and the RNA dimer (D) on the
left. For transcript 92-290, we marked the positions of the
BMH conformation, the BMHtRNA complex, and the dimer
(D) on the right.
|
|
These results argue against the hypothesis that PBS-tRNA-annealing and
the subsequent PAS interaction affect the overall leader RNA structure.
Nevertheless, we observed some other interesting effects in the context
of the mutant BMH transcript 92-290 (Fig. 5, A and
B, lanes 8-14). First, tRNA-annealing seems
slightly less efficient for the BMH transcript compared with the
wild-type LDI transcript, and this effect is most obvious in the
experiment with the intermediate amount of tRNA (4 µg, lanes
3 and 10). This result may suggest that the PBS is more
accessible within the LDI conformation. Second, we observed a small,
but significant effect of tRNA-annealing on the dimerization capacity
of the 92-290 transcript. This tRNA effect is most apparent on the TBM
gel that yields extremely high dimerization efficiencies. A residual
amount of monomeric HIV-1 RNA is present in the absence of tRNA (Fig. 5B, lanes 8 and 11) but disappears at
a certain tRNA concentration (lanes 9 and 10).
The intermediate tRNA sample that was analyzed on the TBE gel is also
very informative as it shows a mixture of monomeric and dimeric RNA
with and without an annealed tRNA primer (Fig. 5A,
lane 10). In this sample, 38% of the tRNA-free transcript
is in the dimeric form, whereas at least 61% of the tRNA-bound
transcript has dimerized. The results obtained in this sensitive
dimerization assay with the 92-290 transcript provides the first
in vitro evidence that reverse transcription events (tRNA-PBS-annealing and/or PAS interaction) may influence the structure
and function of the viral RNA template. Because similar effects are
seen with the anti-PBS probe (lane 12), these tRNA effects
do not provide independent evidence for a PAS-mediated effect.
To elaborate on this result, we tested primer annealing on the set of
mutant HIV-1 transcripts. The wild-type and mutant transcripts were
either mock-incubated or incubated with the anti-PBS probe 202/182 or
the tRNALys3 primer, and samples were analyzed on TBE and
TBM gels (Fig. 6, A and
B). Occupation of the PBS did not trigger dimerization in most cases, but a minor stimulatory effect of the anti-PBS probe is
apparent. Oligonucleotide-induced RNA dimerization is most pronounced
in combination with the 2R mutant transcript that is more
dimerization-prone because of the partial LDI-to-BMH shift (lanes
7 and 8). The mutant 3L transcript also shows a
prominent oligonucleotide-induced effect and, more importantly, a minor tRNA effect (lanes 15). Most informative is the analysis of
the D1 mutant that stably adopts the BMH conformation, which coincides with a relatively high intrinsic dimerization capacity. Approximately 19% dimeric RNA is scored on the TBE gel for the D1 mutant (Fig. 6A, lane 16) that increases to 53% on the TBM
gel (Fig. 6B, lane 16). Annealing of the anti-PBS
DNA oligonucleotide or the natural tRNA primer has a significant
stimulatory effect on the level of RNA dimerization, which is more
pronounced on the TBM gel (lanes 17 and 18).
These combined results argue that PBS-annealing can induce a
conformational switch in the leader RNA that modulates dimerization,
but it is also obvious that tRNA-annealing is not sufficient to induce
the switch.

View larger version (121K):
[in this window]
[in a new window]
|
Fig. 6.
The combined effect of LDI-destabilization
and tRNALys3 annealing. The wild-type and mutant forms
of the 1-290 HIV-1 transcript were either mock-incubated or incubated
with the anti-PBS probe 202/182 or the natural tRNALys3
primer. The samples were analyzed on TBE and TBM gels (panels
A and B). The positions of the fast migrating LDI form
and RNA dimers (D) are marked with arrowheads.
Slow migrating BMH-like complexes are apparent in some samples
(e.g. lane 9). See the text for a further description of the
nature of these vRNA-tRNA complexes.
|
|
The effects of tRNA-annealing on the conformation of the monomeric RNA
are complex, but interesting. The mutations in the 2L and 2R
transcripts open up the PAS stem segment, and both changes cause a
partial shift of the LDI-to-BMH equilibrium (Fig. 4). It is therefore
remarkable that the corresponding vRNA-tRNA complexes differ in their
migration (Fig. 6A, lanes 6 and 9). It
is possible that the slow migrating vRNA-tRNA complex that is
selectively formed by the 2R mutant has established the PAS-antiPAS
interaction (lane 9). This interaction is not possible for
the 2L and 2LR mutants because the PAS motif is mutated, and these
transcripts do not form the slow migrating vRNA-tRNA complex
(lanes 6 and 12). The wild-type template exhibits
an intermediate phenotype (lane 6), probably because the PAS
is not directly available for base pairing with the tRNA. Formation of
the PAS-antiPAS interaction on the 2R template will destabilize the
extended PBS stem and may therefore favor the BMH folding. The slow
migration of this 2R complex is indeed reminiscent of the BMH fold, but
we did not observe induced RNA dimerization, except for the deletion
mutant D1 (lane 13). Interestingly, formation of the slow
migrating vRNA-tRNA complex for the 2R mutant coincides with an
increased reverse transcription activity of this template (9). This
correlation holds up for the other templates, with the ranking order
2R > wt > 2L, 2LR. Mutants 3L and 3R also destabilize the
extended PBS stem and thereby indirectly expose the PAS element.
Indeed, these transcripts form a slowly migrating vRNA-tRNA complex
(Fig. 6A, lane 15 for mutant 3L and results not
shown for mutant 3R). Thus, it seems that the additional PAS-antiPAS
interaction induces a conformational switch of the vRNA-tRNA complex
that makes it an efficient template for reverse transcription. The slow
migration of this complex suggests that formation of the PAS-antiPAS
interaction facilitates the LDI-to-BMH switch.
The Extended PBS Stem Can Absorb Destabilizing Effects--
We
measured a minor effect of tRNA-annealing on the structure and
dimerization properties of the viral RNA template in a sensitive experimental setting. In particular, we used mutant templates in which
the LDI-BMH equilibrium is shifted toward the BMH conformation and that
therefore have a relatively high intrinsic dimerization capacity. We
were not able to provide more direct evidence that tRNA-annealing onto
the PBS and PAS elements can trigger the LDI-to-BMH switch on a
wild-type template. Either gross mutations (e.g. the D1
deletion) or multiple assaults on the PBS domain (e.g.
mutant template plus tRNA-annealing) are required to induce RNA
dimerization. In other words, it appears that the extended PBS stem of
the LDI conformation is relatively resistant to mutational attack.
To directly test this idea, we used the method of
oligonucleotide-scanning arrays (31, 32). The arrays consist of
tethered antisense oligonucleotides that target all possible sequences within the 1-290 HIV-1 leader RNA. This novel methodology can be
successfully used to probe the accessibility of different regions of
the HIV-1 leader RNA.2 We
used this method to score the structural effects of annealing of the
antisense probe 151/123. This probe targets the left side of the
extended PBS stem and is one of the most effective inducers of the
LDI-to-BMH switch and RNA dimerization. The array technology allows us
to discriminate between local melting and complete melting of the
extended PBS stem. If base pairs are melted locally, one would expect
exposure of template nucleotides that flank the annealed probe and
nucleotides on the opposite side of the PBS stem region (around leader
position 220). However, more dramatic changes are expected in case the
extended PBS stem is completely melted, in particular in the poly(A)
and DIS regions that actively participate in this interaction.
We hybridized the array with the Cy5-labeled HIV-1 transcript 1-290
that was either mock-incubated or incubated with the 151/123 probe. The
differential annealing activity is plotted in Fig. 7 as a function of the position on the
leader RNA. The score of 1 indicates that no changes in template
accessibility are apparent upon annealing of the 151/123 probe. Peaks
indicate increased accessibility for oligonucleotide binding upon
annealing of the 151/123 probe. Obviously, no information is obtained
for the region that is targeted by the 151/123 probe itself. Increased
template accessibility is apparent in the region directly upstream of
the annealed oligonucleotide, and such an effect is even more
pronounced in the sequences that are immediately downstream. The
accessibility of the latter region (152-192) increases up to 5.5-fold
upon annealing of the DNA probe, which is consistent with opening of
the U5-top hairpin that is located just upstream of the PBS (Fig.
1C). The PBS sequence does not show an altered accessibility
upon probe annealing. A distinct peak of increased template
accessibility is apparent on the opposite side of the PBS stem, with a
more than 3-fold increase for template position 196-220. This
second-site effect of annealing of the probe 151/123 is restricted to
the 190-226 region, and the differential accessibility returns to the
value of 1 for nucleotides that are positioned further upstream and
downstream. This finding provides independent evidence for the
existence of the base-paired PAS stem as shown in the secondary RNA
structure model of Fig. 1C. There is a small but significant increase in the accessibility of the DIS region, which is consistent with the observed ability of probe 151/123 to induce RNA dimerization. On the other hand, it is clear that the DIS is not fully exposed, and
we measured no increased accessibility in the poly(A) domain. These
results confirm that the extended LDI stem has the capacity to resist a
certain level of destabilization. Similar results were obtained with
shorter antisense oligonucleotides such as 24-mer, 23-mer, etc. (data
not shown).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Oligonucleotide array probing of PBS stem
destabilization. The 1-290 HIV-1 transcript was incubated with
and without the 151/123 antisense probe that is an effective inducer of
the LDI-to-BMH switch and RNA dimerization (see e.g. Fig. 2,
lane 7). An array with all possible 25-mer antisense
oligonucleotides (25/1, 26/2···330/306, 331/307) was used to
probe the conformational differences between these two HIV-1 RNA
samples. In fact, the array also contained all possible 24-, 23-···6-, 5-mers, but we have focused on the results with the
25-mer oligonucleotides. The differential annealing activity is plotted
versus the annealing position of the 3'-end of the antisense
probes. On top we indicated the functional domains of the
HIV-1 leader RNA. Differential annealing data could not be calculated
for oligonucleotides that completely or partially overlap with the
151/123 probe (areas indicated by the black and white
bar) because of competition for the same target-binding site. The
peak of differential annealing activity near the PBS of the RNA
template is represented by probe 196-220.
|
|
 |
DISCUSSION |
We previously reported that the HIV-1 leader RNA can adopt two
mutually exclusive RNA secondary structures, and an RNA switch mechanism was proposed that regulates some of the leader-encoded functions such as RNA dimerization (20, 21). The DIS hairpin motif is
involved in RNA dimerization and is exposed in the BMH leader
conformation. However, the DIS motif is masked by base pairing with the
upstream poly(A) domain in the alternative LDI conformation, which is
thermodynamically more stable. This LDI interaction extends a
base-paired stem that encloses the central PBS domain (Fig.
1C). Using different experimental approaches, we attacked
the PBS stem to measure how much this extended structure should be
destabilized to trigger the LDI-to-BMH switch and concomitant RNA
dimerization. The biological rationale for this study is to analyze
whether structural changes in the upper PBS domain (during reverse
transcription) can influence the overall RNA folding and some of the
leader-encoded functions. Specifically, the tRNALys3 primer
anneals to the PBS motif and subsequently to the PAS motif that forms
the upper segment of the extended PBS stem (9, 10, 30). Indeed, we
measured a small but significant effect of tRNA-annealing on the
LDI-BMH equilibrium and the dimerization properties of the viral RNA.
This is the first demonstration that the processes of reverse
transcription and RNA dimerization may be functionally coupled. This
result was obtained in a simplified in vitro assay system
with naked RNA transcripts, which is likely to differ substantially from the in vivo situation in virion particles. We tried to
mimic the in vivo situation by inclusion of the viral RT
enzyme and the RNA chaperone protein NC, but these conditions are
incompatible with our experimental approach as no discrete RNA
conformations could be distinguished that were due to protein-mediated
bandshifts (results not shown).
Although speculative, one could propose that the cross-talk between
reverse transcription and other leader-mediated processes plays an
important biological role in the viral replication cycle. One
possibility is that the leader RNA conformation is designed to
coordinate the accurate timing of the different leader-encoded functions. In this scenario, it seems possible that early reverse transcription events induce other leader functions such as RNA dimerization and packaging (Fig. 8,
top). This may sound counterintuitive as the order of events
is thought to be reversed in vivo, with initial dimerization
and packaging of the RNA and subsequent reverse transcription. However,
we only probed the effect of tRNA primer annealing, which is the first
step in reverse transcription that may occur relatively early in the
virus-producing cell. This mechanism may be regarded as a safety
feature to ensure that only viral genomes with a properly associated
tRNA primer are allowed to dimerize and to be packaged into virion
particles. Studies with virus mutants are required to critically test
this hypothesis, although we realize that such an analysis will be
complicated due to the presence of multiple overlapping signals in the
HIV-1 leader RNA (2). Furthermore, the presence of a functional PBS sequence with an annealed tRNALys3 primer is not an
absolute requirement for the packaging of apparently regular RNA dimers
into HIV-1 particles (33). The presence of a dimeric RNA genome in
retrovirus particles is clearly instrumental in the later steps of
reverse transcription (33-35), but in this study we specifically
addressed the possibility that conformational changes within the leader
RNA orchestrate early functions during virion assembly. It remains
possible that the virus replication mechanisms are coordinated
differently in vivo than suggested by our in
vitro studies. For instance, it seems possible that RNA
dimerization and/or packaging is mediated by the viral NC protein
through induction of the LDI-to-BMH switch (21). Due to destabilization
of the extended PBS stem, the PAS may become accessible for annealing
to and activation of the tRNA primer for reverse transcription (Fig. 8,
bottom). Whatever the precise mechanism, the presence of an
RNA switch mechanism allows the coordination of different RNA-mediated
functions. It is also possible that the same leader RNA switch is
involved in the decision of a full-length viral RNA to act as mRNA
for translation by ribosomes or as genomic RNA that is encapsulated in
virions. This possibility becomes more realistic because we have
recently found interactions between the upstream and downstream leader
domains, which include the translational initiation region and the AUG
start codon.3 Although viral
proteins may modulate this RNA switch, we propose that it is the RNA
itself that forms the intrinsic checkpoint for the production of
infectious virus particles with a dimeric- and reverse
transcription-competent RNA genome.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
The HIV-1 leader RNA as checkpoint that
coordinates different replication functions. The LDI is the
ground-state conformation that is dimerization- and reverse
transcription-incompetent due to masking of the DIS and PAS motifs (9,
10, 21). Two possible scenarios are indicated: top,
tRNA-annealing via the PBS and PAS motifs mediates the LDI-to-BMH
switch, which exposes the DIS and allows RNA dimerization (this study);
bottom, NC protein facilitates the LDI-to-BMH switch and RNA
dimer formation (21). The initial tRNA-PBS interaction may occur in the
LDI-context, but the PAS motif may only become accessible after the
switch to the BMH structure, thus facilitating initiation of reverse
transcription. See the text for further details. We did not include the
process of RNA packaging in this mechanistic model, but packaging may
be coupled to RNA dimerization.
|
|
Another intriguing finding is that a major destabilization of the
lengthy PBS-LDI stem is required to induce the LDI-to-BMH conformational switch. The extended nature of the PBS-LDI stem makes it
relatively resistant to the impact of minor destabilizing mutations or
antisense oligonucleotides. In a biological setting, this may indicate
that HIV-1 needs tight control over the process of RNA dimerization.
Premature RNA dimerization may for instance interfere with the process
of mRNA translation (36) and should therefore be restricted to
viral RNA genomes that participate in the assembly of virus particles.
Interestingly, we previously demonstrated that the viral NC protein can
mediate the LDI-to-BMH switch (21). Because this RNA chaperone protein
is released form the Gag precursor protein during the late stage of
virus assembly, this mechanism will ensure the proper timing of RNA dimerization. Even though the LDI stem can adsorb mutations because of
its extended nature, this RNA structure is not excessively stable in
thermodynamic terms (21). This is due to the presence of multiple
destabilizing bulge or internal loop elements (Fig. 1C). In
fact, we previously demonstrated that further stabilization of this
duplex leads to a severe replication defect, and such a mutant template
cannot easily be reverse-transcribed (29). These mutant RNA templates
also demonstrate a severe in vitro RNA dimerization
defect,4 thereby confirming
the inverse correlation between LDI folding and RNA dimer formation.
The apparent damage tolerance of the extended PBS stem in the LDI
conformation is similar to what has been described as error and attack
tolerance of complex biological networks (37). The ability of the
base-paired stem to absorb mutations may explain a paradox that could
not be resolved previously. The individual hairpin motifs of the BMH
conformation are readily supported by phylogenetic analysis. Different
virus isolates show many base-pair co-variations that change the
nucleotide sequence but not the base pairing within the poly(A) and DIS
hairpins (24, 38). However, there is no such support for the base pairs
of the LDI conformation. We proposed the LDI base-pairing scheme based
on multiple experimental lines of evidence (21), but we found little phylogenetic support for this interaction in terms of base-pair co-variations. We now realize that base pairs in the extended LDI stem
are under limited evolutionary pressure because single point mutations
will not have a major impact on LDI folding and function. In contrast,
the same point mutation is much more likely to have a significant
destabilizing effect on the hairpins of the BMH conformation, and
second-side mutations will primarily be selected for their property to
repair the hairpins.
 |
ACKNOWLEDGEMENTS |
We thank Oxford Gene Technologies (Tim Fell,
Pete Corish, Simon Orange, Angela Newton, Helen Newton) for synthesis
and help with the design of oligonucleotide arrays and for technical
advice with the hybridization reactions and Wim van Est for photography work.
 |
FOOTNOTES |
*
This work was supported in part by The Netherlands
Foundation for Chemical Research with financial aid from The
Netherlands Organization for Scientific Research (NWO-CW).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Human
Retrovirology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Tel.:
31-20-566-4822; Fax: 31-20-566-6064; E-mail: b.berkhout@amc.uva.nl;
Web address: www.berkhoutlab.com.
Supported by a European Molecular Biology Organization fellowship.
Published, JBC Papers in Press, March 14, 2002, DOI 10.1074/jbc.M200950200
2
K. Verhoef et al., manuscript in preparation.
3
T. E. M. Abbink and B. Berkhout,
unpublished results.
4
H. Huthoff and B. Berkhout, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
HIV-1, human
immunodeficiency virus, type 1;
LDI, long distance interaction;
PBS, primer-binding site;
BMH, branched multiple hairpin;
LTR, long terminal
repeat;
PAS, primer activation signal;
DIS, dimer initiation signal;
NC, nucleocapsid;
TBE, Tris borate/EDTA;
TBM, Tris
borate/MgCl2.
 |
REFERENCES |
| 1.
|
Berkhout, B.
(1996)
Progr. Nucleic Acids Res. Mol. Biol.
54,
1-34[Medline]
[Order article via Infotrieve]
|
| 2.
|
Berkhout, B.
(2000)
Adv. Pharmacol.
48,
29-73
|
| 3.
|
Dingwall, C.,
Ernberg, I.,
Gait, M. J.,
Green, S. M.,
Heaphy, S.,
Karn, J.,
Lowe, A. D.,
Singh, M.,
Skinner, M. A.,
and Valerio, R.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
6925-6929[Abstract/Free Full Text]
|
| 4.
|
Wei, P.,
Garber, M. E.,
Fang, S.-M.,
Fisher, W. H.,
and Jones, K. A.
(1998)
Cell
92,
451-462[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Berkhout, B.,
Silverman, R. H.,
and Jeang, K. T.
(1989)
Cell
59,
273-282[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Klasens, B. I. F.,
Thiesen, M.,
Virtanen, A.,
and Berkhout, B.
(1999)
Nucleic Acids Res.
27,
446-454[Abstract/Free Full Text]
|
| 7.
|
Klasens, B. I. F.,
Das, A. T.,
and Berkhout, B.
(1998)
Nucleic Acids Res.
26,
1870-1876[Abstract/Free Full Text]
|
| 8.
|
Berkhout, B.,
Vastenhouw, N. L.,
Klasens, B. I.,
and Huthoff, H.
(2001)
RNA.
7,
1097-1114[Abstract]
|
| 9.
|
Beerens, N.,
Groot, F.,
and Berkhout, B.
(2001)
J. Biol. Chem.
276,
31247-31256[Abstract/Free Full Text]
|
| 10.
|
Beerens, N.,
and Berkhout, B.
(2002)
J. Virol.
76,
2329-2339[Abstract/Free Full Text]
|
| 11.
|
Laughrea, M.,
and Jette, L.
(1994)
Biochemistry
33,
13464-13474[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Shen, N.,
Jette, L.,
Wainberg, M. A.,
and Laughrea, M.
(2001)
J. Virol.
75,
10543-10549[Abstract/Free Full Text]
|
| 13.
|
Takahashi, K.-I.,
Baba, S.,
Chattopadhyay, P.,
Koyanagi, Y.,
Yamamoto, N.,
Takaku, H.,
and Kawai, G.
(2000)
RNA
6,
96-102[Abstract]
|
| 14.
|
Lodmell, J. S.,
Ehresmann, C.,
Ehresmann, B.,
and Marquet, R.
(2000)
RNA
6,
1267-1276[Abstract]
|
| 15.
|
Jossinet, F.,
Paillart, J.-C.,
Westhof, E.,
Hermann, T.,
Skripkin, E.,
Lodmell, J. S.,
Ehresmann, C.,
Ehresmann, B.,
and Marquet, R.
(1999)
RNA
5,
1222-1234[Abstract]
|
| 16.
|
Skripkin, E.,
Paillart, J. C.,
Marquet, R.,
Ehresmann, B.,
and Ehresmann, C.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
4945-4949[Abstract/Free Full Text]
|
| 17.
|
Mujeeb, A.,
Parslow, T. G.,
Zarrinpar, A.,
Das, C.,
and James, T. L.
(1999)
FEBS Lett.
458,
387-392[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Clever, J.,
Sassetti, C.,
and Parslow, T. G.
(1995)
J. Virol.
69,
2101-2109[Abstract]
|
| 19.
|
De Guzman, R. N.,
Rong Wu, Z.,
Stalling, C. C.,
Pappalardo, L.,
Borer, P. N.,
and Summers, M. F.
(1998)
Science
279,
384-388[Abstract/Free Full Text]
|
| 20.
|
Berkhout, B.,
and van Wamel, J. L. B.
(2000)
RNA
6,
282-295[Abstract]
|
| 21.
|
Huthoff, H.,
and Berkhout, B.
(2001)
RNA
7,
143-157[Abstract]
|
| 22.
|
Das, A. T.,
Klaver, B.,
Klasens, B. I. F.,
van Wamel, J. L. B.,
and Berkhout, B.
(1997)
J. Virol.
71,
2346-2356[Abstract]
|
| 23.
|
Peden, K. W. C.,
and Martin, M. A.
(1996)
in
HIV, A Practical Approach
(Karn, J., ed)
, IRL Press at Oxford University Press, Oxford, New York
|
| 24.
|
Berkhout, B.,
and van Wamel, J. L. B.
(1996)
J. Virol.
70,
6723-6732[Abstract/Free Full Text]
|
| 25.
|
Hughes, T. R.,
Mao, M.,
Jones, A. R.,
Burchard, J.,
Marton, M. J.,
Shannon, K. W.,
Lefkowitz, S. M.,
Ziman, M.,
Schelter, J. M.,
Meyer, M. R.,
Kobayashi, S.,
Davis, C.,
Dai, H., He, Y. D.,
Stephaniants, S. B.,
Cavet, G.,
Walker, W. L.,
West, A.,
Coffey, E.,
Shoemaker, D. D.,
Stoughton, R.,
Blanchard, A. P.,
Friend, S. H.,
and Linsley, P. S.
(2001)
Nat. Biotechnol.
19,
342-347[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Shoemaker, D. D.,
Schadt, E. E.,
Armour, C. D., He, Y. D.,
Garrett-Engele, P.,
McDonagh, P. D.,
Loerch, P. M.,
Leonardson, A.,
Lum, P. Y.,
Cavet, G., Wu, L. F.,
Altschuler, S. J.,
Edwards, S.,
King, J.,
Tsang, J. S.,
Schimmack, G.,
Schelter, J. M.,
Koch, J.,
Ziman, M.,
Marton, M. J., Li, B.,
Cundiff, P.,
Ward, T.,
Castle, J.,
Krolewski, M.,
Meyer, M. R.,
Mao, M.,
Burchard, J.,
Kidd, M. J.,
Dai, H.,
Phillips, J. W.,
Linsley, P. S.,
Stoughton, R.,
Scherer, S.,
and Boguski, M. S.
(2001)
Nature
409,
922-927[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Huthoff, H.,
and Berkhout, B.
(2001)
Nucleic Acids Res.
29,
2594-2600[Abstract/Free Full Text]
|
| 28.
|
Beerens, N.,
and Berkhout, B.
(2000)
J. Biol. Chem.
275,
15474-15481[Abstract/Free Full Text]
|
| 29.
|
Beerens, N.,
Groot, F.,
and Berkhout, B.
(2000)
Nucleic Acids Res.
28,
4130-4137[Abstract/Free Full Text]
|
| 30.
|
Beerens, N.,
and Berkhout, B.
(2002)
RNA
8,
357-369[Abstract]
|
| 31.
|
Sohail, M.,
Hochegger, H.,
Klotzbucher, A.,
Guellec, R. L.,
Hunt, T.,
and Southern, E. M.
(2001)
Nucleic Acids Res.
29,
2041-2051[Abstract/Free Full Text]
|
| 32.
|
Sohail, M.,
and Southern, E. M.
(2000)
Mol. Cell. Biol. Res. Commun.
3,
67-72[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Berkhout, B.,
Das, A. T.,
and van Wamel, J. L. B.
(1998)
Virology
249,
211-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Paillart, J.-C.,
Berthoux, L.,
Ottmann, M.,
Darlix, J.-L.,
Marquet, R.,
Ehresmann, B.,
and Ehresmann, C.
(1996)
J. Virol.
70,
8348-8354[Abstract]
|
| 35.
|
Balakrishnan, M.,
Fay, P. J.,
and Bambara, R. A.
(2001)
J. Biol. Chem.
276,
36482-36492[Abstract/Free Full Text]
|
| 36.
|
Bieth, E.,
Gabus, C.,
and Darlix, J.-L.
(1990)
Nucleic Acids Res.
18,
119-127[Abstract/Free Full Text]
|
| 37.
|
Albert, R.,
Jeong, H.,
and Barabasi, A. L.
(2000)
Nature
406,
378-382[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Berkhout, B.,
Klaver, B.,
and Das, A. T.
(1995)
Virol.
207,
276-281
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Vrolijk, M. Ooms, A. Harwig, A. T. Das, and B. Berkhout
Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA
Nucleic Acids Res.,
August 1, 2008;
36(13):
4352 - 4363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sinck, D. Richer, J. Howard, M. Alexander, D. F.J. Purcell, R. Marquet, and J.-C. Paillart
In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs
RNA,
December 1, 2007;
13(12):
2141 - 2150.
[Abstract]
[Full Text]
[PDF]
|
 |
|